Lifecore Biomedical Inc
NASDAQ:LFCR
Lifecore Biomedical Inc
Free Cash Flow
Lifecore Biomedical Inc
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lifecore Biomedical Inc
NASDAQ:LFCR
|
Free Cash Flow
-$14.4m
|
CAGR 3-Years
27%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Hershey Co
NYSE:HSY
|
Free Cash Flow
$1.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
13%
|
|
|
General Mills Inc
NYSE:GIS
|
Free Cash Flow
$2.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
Kellogg Co
NYSE:K
|
Free Cash Flow
$1.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-1%
|
|
|
Kraft Heinz Co
NASDAQ:KHC
|
Free Cash Flow
$3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
2%
|
CAGR 10-Years
6%
|
|
|
Mondelez International Inc
NASDAQ:MDLZ
|
Free Cash Flow
$3.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
Lifecore Biomedical Inc
Glance View
Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.
See Also
What is Lifecore Biomedical Inc's Free Cash Flow?
Free Cash Flow
-14.4m
USD
Based on the financial report for Nov 24, 2024, Lifecore Biomedical Inc's Free Cash Flow amounts to -14.4m USD.
What is Lifecore Biomedical Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
21%
Over the last year, the Free Cash Flow growth was 68%. The average annual Free Cash Flow growth rates for Lifecore Biomedical Inc have been 27% over the past three years , 21% over the past five years .
You don't have any saved screeners yet